BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 15557422)

  • 1. A change in definition results in an increased number of adults with prediabetes in the United States.
    Benjamin SM; Cadwell BL; Geiss LS; Engelgau MM; Vinicor F
    Arch Intern Med; 2004 Nov; 164(21):2386. PubMed ID: 15557422
    [No Abstract]   [Full Text] [Related]  

  • 2. Combating the diabetes epidemic.
    Senemmari B
    Caring; 2005 Jun; 24(6):6-12. PubMed ID: 16035266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of undiagnosed diabetes and prediabetic states in high-risk emergency department patients.
    Charfen MA; Ipp E; Kaji AH; Saleh T; Qazi MF; Lewis RJ
    Acad Emerg Med; 2009 May; 16(5):394-402. PubMed ID: 19302369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New diabetes guidelines: a closer look at the evidence.
    Woolf SH; Rothemich SF
    Am Fam Physician; 1998 Oct; 58(6):1287-8, 1290. PubMed ID: 9803186
    [No Abstract]   [Full Text] [Related]  

  • 5. Does the new American Diabetes Association definition for impaired fasting glucose improve its ability to predict type 2 diabetes mellitus in Spanish persons? The Asturias Study.
    Valdés S; Botas P; Delgado E; Alvarez F; Cadórniga FD
    Metabolism; 2008 Mar; 57(3):399-403. PubMed ID: 18249214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raised fasting plasma glucose a better predictor of diabetes than the IDF definition of the metabolic syndrome.
    Nakagami T; Tajima N; Oizumi T; Karasawa S; Wada K; Kameda W; Suga S; Kato T; Daimon M
    Diabetes Res Clin Pract; 2009 Aug; 85(2):e19-21. PubMed ID: 19493584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study.
    Levitzky YS; Pencina MJ; D'Agostino RB; Meigs JB; Murabito JM; Vasan RS; Fox CS
    J Am Coll Cardiol; 2008 Jan; 51(3):264-70. PubMed ID: 18206734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-reported prediabetes and risk-reduction activities--United States, 2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Nov; 57(44):1203-5. PubMed ID: 18987616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus.
    Ozeki N; Hara K; Yatsuka C; Nakano T; Matsumoto S; Suetsugu M; Nakamachi T; Takebayashi K; Inukai T; Haruki K; Aso Y
    Metabolism; 2009 Oct; 58(10):1470-6. PubMed ID: 19592051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of prediabetes in Kashmir valley using revised ADA criteria for impaired fasting glycemia.
    Zargar AH; Bashir MI; Masoodi SR; Wani AI; Khan AK
    Diabetes Res Clin Pract; 2006 Jun; 72(3):329-30. PubMed ID: 16338018
    [No Abstract]   [Full Text] [Related]  

  • 11. Third-party reimbursement for diabetes care, self-management education, and supplies.
    American Diabetes Association
    Diabetes Care; 2008 Jan; 31 Suppl 1():S95-6. PubMed ID: 18165343
    [No Abstract]   [Full Text] [Related]  

  • 12. Association of sleep time with diabetes mellitus and impaired glucose tolerance.
    Gottlieb DJ; Punjabi NM; Newman AB; Resnick HE; Redline S; Baldwin CM; Nieto FJ
    Arch Intern Med; 2005 Apr; 165(8):863-7. PubMed ID: 15851636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study.
    Brown TT; Cole SR; Li X; Kingsley LA; Palella FJ; Riddler SA; Visscher BR; Margolick JB; Dobs AS
    Arch Intern Med; 2005 May; 165(10):1179-84. PubMed ID: 15911733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications for primary care of diabetes and impaired fasting glucose prevalence in adolescents.
    Rosenbloom AL
    Arch Pediatr Adolesc Med; 2006 May; 160(5):550-2. PubMed ID: 16651502
    [No Abstract]   [Full Text] [Related]  

  • 15. The relationship of hepatitis antibodies and elevated liver enzymes with impaired fasting glucose and undiagnosed diabetes.
    Mainous AG; Diaz VA; King DE; Everett CJ; Player MS
    J Am Board Fam Med; 2008; 21(6):497-503. PubMed ID: 18988716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of lower extremity diseases associated with normal glucose levels, impaired fasting glucose, and diabetes among U.S. adults aged 40 or older.
    Gregg EW; Gu Q; Williams D; de Rekeneire N; Cheng YJ; Geiss L; Engelgau M
    Diabetes Res Clin Pract; 2007 Sep; 77(3):485-8. PubMed ID: 17306411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of diagnosed and undiagnosed diabetes mellitus and impaired fasting glucose in Sardinia.
    Muntoni S; Atzori L; Mereu R; Manca A; Satta G; Gentilini A; Bianco P; Baule A; Baule GM; Muntoni S
    Acta Diabetol; 2009 Sep; 46(3):227-31. PubMed ID: 19107322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re: A comparison of classification schemes for ketosis-prone diabetes.
    Nalini R; Maldonado M; Balasubramanyam A
    Nat Clin Pract Endocrinol Metab; 2007 Dec; 3(12):E1. PubMed ID: 18026157
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevalence and trends of insulin resistance, impaired fasting glucose, and diabetes.
    Ioannou GN; Bryson CL; Boyko EJ
    J Diabetes Complications; 2007; 21(6):363-70. PubMed ID: 17967708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence of heart failure among nondiabetic patients with and without impaired fasting glucose.
    Nichols GA; Koro CE; Kolatkar NS
    J Diabetes Complications; 2009; 23(3):224-8. PubMed ID: 18413158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.